Affimed Plunges 20% as Insolvency Filing Looms

On May 15, 2025, Affimed's stock experienced a significant drop of 20% in pre-market trading, reflecting the market's reaction to recent developments surrounding the company.

Affimed N.V. has filed for insolvency proceedings, which has led to the suspension and potential delisting of its shares from the Nasdaq. This move has significantly impacted investor confidence and share value. The company's shares are set to be delisted from Nasdaq due to insolvency, with trading of AFMD shares ceasing on May 20, 2025. Affimed has decided not to appeal the Nasdaq's decision.

In addition to the insolvency filing, Affimed has also received a Nasdaq notice of non-compliance, further complicating its financial situation. The company has delayed the filing of its 2024 yearly report, adding to the list of challenges it faces. These developments have collectively contributed to the recent decline in Affimed's stock price, as investors grapple with the uncertainty surrounding the company's future.